Solutions For CDMOs

Execution Capacity for CDMOs Scaling Faster Than Their Systems Can Keep Up.

Syner-G embeds science, strategy, and hands-on execution talent inside CDMOs to close capacity, quality, and tech transfer gaps, without the overhead of a full-time hire.

Talk to Our Team

CDMOs are scaling faster than their operational infrastructure can support.

New capacity, modalities, clients, and investors are putting pressure on teams still running on legacy systems and lean headcount. Validation backlogs grow. Tech transfers stall. Onboarding takes too long. And the gap between what was sold and what can be delivered gets harder to close quietly.

Challenges we can help solve

Capacity commitments outpacing qualified resources and validated systems
Cell & gene therapy, biologics, and emerging modality programs moving faster than GMP infrastructure can mature
Client onboarding and tech transfer timelines slipping under deal pressure
Expansion projects competing with day-to-day operational priorities

Strategy is Only Valuable When It Gets Executed.

Syner-G goes beyond recommendations. We embed experienced technical operations leaders, SMEs, and project teams directly into your organization to execute alongside your teams. From validation and CQV execution to tech transfer infrastructure, new modality readiness, and expansion programs, we help close execution gaps without adding permanent overhead.

1. Capacity & Operational Scalability
Right-size facility and equipment capacity to match committed client volume.
2. GMP Operational Readiness for New Modalities
Enable accelerated launch of cell & gene therapy, biologics, and emerging modalities through GMP-ready systems, processes, and infrastructure.
3. Tech Transfer & Client Readiness
Build repeatable tech transfer and client onboarding models that reduce cycle time and execution risk.
4. Digital Infrastructure Enablement
Implement and validate critical operational systems, including CMMS and BMS platforms, to support reliable maintenance, compliance, and facility performance.
5. Expansion Program Management
Lead complex facility build-outs, line additions, and footprint expansion end to end while maintaining operational continuity.

Proof, not promises.

Radiopharmaceutical CDMO

Supported facility startup readiness with an embedded five-person CQV and technical team, growing an initial assignment into a significantly expanded partnership through strong execution and earned client trust.

Global peptide CDMO

Delivered 262 CQV deliverables across 30+ systems with 2 resources providing hands-on execution support. Directed the successful completion of 262 CQV deliverables across 30+ systems with a two-person technical team, driving efficient project execution.

Biologics CDMO

Delivered an 11-week Lean transformation that improved operational performance and led to an expanded role providing ongoing PMO oversight for continued process optimization and sustain operational improvements.

Sterile injectables CDMO

Implemented Veeva documentation workflows through an integrated 6-person team model, earning client recognition: “Thanks for acting with urgency.”

Find out where your execution gaps are.

Most CDMOs don’t find their capacity, quality, or onboarding gaps until a client does. Let’s talk before that happens.

Schedule a Conversation

Solutions For CDMOs

CDMOs are scaling faster than their operational infrastructure can support.

Strategy is Only Valuable When It Gets Executed.

1. Capacity & Operational Scalability

2. GMP Operational Readiness for New Modalities

3. Tech Transfer & Client Readiness

4. Digital Infrastructure Enablement

5. Expansion Program Management